NCT03283436View on ClinicalTrials.gov

RCT Superior Hypogastric Block During LH

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 18, 2018

Primary Completion Date

February 21, 2019

Study Completion Date

February 21, 2019

Conditions
Hysterectomy
Interventions
DRUG

Bupivacaine Hydrochloride 0.25% Injection Solution

10 mL of 0.25% bupivacaine hydrochloride (2.5 mg/mL = 25 mg)

Trial Locations (2)

02115

Brigham & Women's Hospital, Boston

02130

Faulkner Hospital, Boston

All Listed Sponsors
collaborator

University of North Carolina

OTHER

collaborator

George Washington University

OTHER

lead

Jon I. Einarsson

OTHER

NCT03283436 - RCT Superior Hypogastric Block During LH | Biotech Hunter | Biotech Hunter